Apollo Hospitals Enterprise Limited (BOM:508869)
7,538.25
+1.10 (0.01%)
At close: Feb 13, 2026
BOM:508869 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 242,152 | 217,940 | 190,592 | 166,125 | 146,626 | 105,600 |
Revenue | 242,152 | 217,940 | 190,592 | 166,125 | 146,626 | 105,600 |
Revenue Growth (YoY) | 14.52% | 14.35% | 14.73% | 13.30% | 38.85% | -6.11% |
Cost of Revenue | 159,199 | 144,440 | 126,608 | 109,446 | 95,317 | 74,204 |
Gross Profit | 82,953 | 73,500 | 63,984 | 56,679 | 51,309 | 31,396 |
Selling, General & Admin | 7,185 | 7,185 | 8,104 | 7,829 | 4,669 | 2,635 |
Other Operating Expenses | 40,374 | 35,983 | 31,937 | 28,204 | 24,749 | 17,358 |
Operating Expenses | 56,186 | 50,743 | 46,911 | 42,187 | 35,425 | 25,724 |
Operating Income | 26,767 | 22,757 | 17,073 | 14,492 | 15,884 | 5,672 |
Interest Expense | -4,093 | -4,225 | -4,101 | -3,137 | -3,304 | -4,058 |
Interest & Investment Income | 930 | 930 | 429 | 445 | 351 | 218 |
Earnings From Equity Investments | 453 | 330 | 180 | -432 | 73 | 8 |
Currency Exchange Gain (Loss) | - | - | - | 3 | 6 | -41 |
Other Non Operating Income (Expenses) | -50 | -135 | -153 | -532 | -310 | -250 |
EBT Excluding Unusual Items | 24,007 | 19,657 | 13,428 | 10,839 | 12,700 | 1,549 |
Gain (Loss) on Sale of Investments | 774 | 774 | 374 | 285 | 253 | 89 |
Gain (Loss) on Sale of Assets | -63 | -63 | -36 | -150 | -40 | -29 |
Other Unusual Items | -169 | 23 | 39 | 31 | 2,941 | 606 |
Pretax Income | 24,549 | 20,391 | 13,805 | 11,005 | 15,854 | 2,215 |
Income Tax Expense | 5,891 | 5,340 | 4,455 | 2,562 | 4,770 | 847 |
Earnings From Continuing Operations | 18,658 | 15,051 | 9,350 | 8,443 | 11,084 | 1,368 |
Minority Interest in Earnings | -639 | -592 | -364 | -252 | -528 | 136 |
Net Income | 18,019 | 14,459 | 8,986 | 8,191 | 10,556 | 1,504 |
Net Income to Common | 18,019 | 14,459 | 8,986 | 8,191 | 10,556 | 1,504 |
Net Income Growth | 37.54% | 60.91% | 9.71% | -22.40% | 601.86% | -66.94% |
Shares Outstanding (Basic) | 144 | 144 | 144 | 144 | 144 | 140 |
Shares Outstanding (Diluted) | 144 | 144 | 144 | 144 | 144 | 140 |
Shares Change (YoY) | -0.01% | - | - | - | 2.71% | 0.62% |
EPS (Basic) | 125.33 | 100.56 | 62.50 | 56.97 | 73.42 | 10.74 |
EPS (Diluted) | 125.33 | 100.56 | 62.50 | 56.97 | 73.42 | 10.74 |
EPS Growth | 37.55% | 60.91% | 9.71% | -22.40% | 583.57% | -67.15% |
Free Cash Flow | - | 4,237 | 7,834 | 2,484 | 10,388 | 9,692 |
Free Cash Flow Per Share | - | 29.47 | 54.48 | 17.28 | 72.25 | 69.23 |
Dividend Per Share | 20.000 | 19.000 | 16.000 | 15.000 | 11.750 | 3.000 |
Dividend Growth | 5.26% | 18.75% | 6.67% | 27.66% | 291.67% | -50.00% |
Gross Margin | 34.26% | 33.73% | 33.57% | 34.12% | 34.99% | 29.73% |
Operating Margin | 11.05% | 10.44% | 8.96% | 8.72% | 10.83% | 5.37% |
Profit Margin | 7.44% | 6.63% | 4.71% | 4.93% | 7.20% | 1.42% |
Free Cash Flow Margin | - | 1.94% | 4.11% | 1.49% | 7.08% | 9.18% |
EBITDA | 32,129 | 27,982 | 22,115 | 19,106 | 20,455 | 9,754 |
EBITDA Margin | 13.27% | 12.84% | 11.60% | 11.50% | 13.95% | 9.24% |
D&A For EBITDA | 5,362 | 5,225 | 5,042 | 4,614 | 4,571 | 4,082 |
EBIT | 26,767 | 22,757 | 17,073 | 14,492 | 15,884 | 5,672 |
EBIT Margin | 11.05% | 10.44% | 8.96% | 8.72% | 10.83% | 5.37% |
Effective Tax Rate | 24.00% | 26.19% | 32.27% | 23.28% | 30.09% | 38.24% |
Revenue as Reported | 244,240 | 219,943 | 191,655 | 167,028 | 147,408 | 106,050 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.